एपीए उद्धरण

Palazzo, M., Shah, G. L., Copelan, O., Seier, K., Devlin, S. M., Maloy, M., . . . Perales, M. (2017). Re-vaccination following Autologous Hematopoietic Stem Cell Transplantation is Safe and Effective in Patients with Multiple Myeloma Receiving Lenalidomide Maintenance. Biol Blood Marrow Transplant.

शिकागो स्टाइल उद्धरण

Palazzo, Meighan, et al. "Re-vaccination Following Autologous Hematopoietic Stem Cell Transplantation Is Safe and Effective in Patients With Multiple Myeloma Receiving Lenalidomide Maintenance." Biol Blood Marrow Transplant 2017.

एमएलए उद्धरण

Palazzo, Meighan, et al. "Re-vaccination Following Autologous Hematopoietic Stem Cell Transplantation Is Safe and Effective in Patients With Multiple Myeloma Receiving Lenalidomide Maintenance." Biol Blood Marrow Transplant 2017.

चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.